MedTrace Logo

Treatment Response to Xiaflex for Men With Peyronie's Disease

NCT03774264 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-09-29

No results posted yet for this study

Summary

The purpose of this research study is to develop a database of patients with Peyronie's disease who are treated at the University of Miami. The collected data will help the researchers to better understand Peyronie's disease and its response to therapy.

Conditions

  • Peyronie Disease

Sponsors & Collaborators

  • Endo Pharmaceuticals

    collaborator INDUSTRY

  • University of Miami

    lead OTHER

Principal Investigators

  • Ranjith Ramasamy, MD · University of Miami

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-02
Primary Completion
2021-07-02
Completion
2021-07-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03774264 on ClinicalTrials.gov